🇺🇸 FDA
Pipeline program

Minzasolmin, UCB0599 PRD4385815

UP0152

Phase 1 small_molecule active

Quick answer

Minzasolmin, UCB0599 PRD4385815 for Healthy Participants is a Phase 1 program (small_molecule) at Lacuna Pharma Pty Ltd with 1 ClinicalTrials.gov record(s).

Program details

Company
Lacuna Pharma Pty Ltd
Indication
Healthy Participants
Phase
Phase 1
Modality
small_molecule
Status
active

Clinical trials